Rasagiline Krka 1 mg tabl.

País: Bèlgica

Idioma: anglès

Font: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ingredients actius:

Rasagiline Mesylate 1,44 mg - Eq. Rasagiline 1 mg

Disponible des:

Krka d.d. Novo mesto d.d.

Codi ATC:

N04BD02

Designació comuna internacional (DCI):

Rasagiline Mesilate

Dosis:

1 mg

formulario farmacéutico:

Tablet

Composición:

Rasagiline Mesilate 1.44 mg

Vía de administración:

Oral use

Área terapéutica:

Rasagiline

Resumen del producto:

CTI code: 483324-10 - Pack size: 112 (112 x 1) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 483324-09 - Pack size: 112 - Commercialisation status: YES - FMD code: 03838989692803 - CNK code: 3430485 - Delivery mode: Medical prescription; CTI code: 483324-07 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 483324-08 - Pack size: 30 (30 x 1) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 483324-05 - Pack size: 28 - Commercialisation status: YES - FMD code: 03838989692797 - CNK code: 3430477 - Delivery mode: Medical prescription; CTI code: 483324-06 - Pack size: 28 (28 x 1) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 483324-03 - Pack size: 15 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 483324-04 - Pack size: 15 (15 x 1) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 483324-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 483324-02 - Pack size: 14 (14 x 1) - Commercialisation status: NO - Delivery mode: Medical prescription

Estat d'Autorització:

Commercialised: Yes

Data d'autorització:

2015-12-04